At the cellular level, CLCA2 inhibits the WNT signaling pathway [72] or the ERK/JNK/p38-MAPK pathway to suppress epithelial-mesenchymal transition (EMT) [73, 74], thereby impeding tumor metastasis. Here, CLCA2 is linked to neoplasm.